Dr. Reddy’s Laboratories gets approval for phase 3 trials of Sputnik V Covid-19 vaccine

12 Jan 2021 Evaluate

Dr. Reddy’s Laboratories has got approval from the independent Data and Safety Monitoring Board (DSMB) for phase 3 trials of Russia's Sputnik V Covid-19 vaccine. DSMB’s clearance is based on the safety data from the phase 2 clinical trial. The company is running the clinical trial for the Sputnik V vaccine in India in partnership with the Russian Investment Development Fund.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1275.05 -1.95 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×